Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 55, Issue 5, 2016, Pages 359-366

  Malm, Heli ^a,b   Brown, Alan S ^d,e,f   Gissler, Mika ^b,g   Gyllenberg, David ^a,b   Hinkka Yli Salomäki, Susanna ^b   McKeague, Ian W ^e   Weissman, Myrna ^d,e,f   Wickramaratne, Priya ^d,e,f   Artama, Miia ^h   Gingrich, Jay A ^d,f   Sourander, Andre ^b,c,d,f  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d College of Physic and Surg ^*  (United States)

^e Department of Medicine   (United States)

^f NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^h FINNISH CANCER REGISTRY   (Finland)

Author keywords

ADHD; ASD; offspring depression; pregnancy; SSRI

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; NERVOUS SYSTEM DEVELOPMENT; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; REGISTER; ADOLESCENT; BIPOLAR DISORDER; CHEMICALLY INDUCED; FOLLOW UP; MATERNAL EXPOSURE; PREGNANCY; PRENATAL EXPOSURE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISM SPECTRUM DISORDER; BIPOLAR DISORDER; DEPRESSIVE DISORDER; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; MATERNAL EXPOSURE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REGISTRIES; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 84961777347     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1016/j.jaac.2016.02.013     Document Type: Article

References (29)

1. M.S. Ansorge, M. Zhou, A. Lira, R. Hen, and J.A. Gingrich Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice Science 306 2004 879 881
2. M.S. Ansorge, E. Morelli, and J.A. Gingrich Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice J Neurosci 28 2008 199 207
3. T.F. Oberlander, J.A. Gingrich, and M.S. Ansorge Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence Clin Pharmacol Ther 86 2009 672 677
4. J. Rampono, K. Simmer, K.F. Ilett, and et al. Placental transfer of SSRI and SNRI antidepressants and effects on the neonate Pharmacopsychiatry 42 2009 95 100
5. H. Malm, M. Artama, A.S. Brown, and et al. Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI) BMC Psychiatry 12 2012 217
6. K.F. Huybrechts, K. Palmsten, H. Mogun, and et al. National trends in antidepressant medication treatment among publicly insured pregnant women Gen Hosp Psychiatry 35 2013 265 271
7. M.M. Weissman, P. Wickramaratne, Y. Nomura, V. Warner, D. Pilowsky, and H. Verdeli Offspring of depressed parents: 20 years later Am J Psychiatry 163 2006 1001 1008
8. D. Gyllenberg, M. Gissler, H. Malm, and et al. Specialized service use for psychiatric and neurodevelopmental disorders by age 14 in Finland Psychiatr Serv 65 2014 367 373
9. A. Hviid, M. Melbye, and B. Pasternak Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism N Eng J Med 369 2013 2406 2415
10. M.J. Sørensen, T.K. Grønborg, J. Christensen, and et al. Antidepressant exposure in pregnancy and risk of autism spectrum disorders Clin Epidemiol 5 2013 449 459
11. C.C. Clements, V.M. Castro, S.R. Blumenthal, and et al. Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system Mol Psychiatry 20 2015 727 734
12. K. Laugesen, M.S. Olsen, A.B. Telén Andersen, T. Frøslev, and H.T. Sørensen In utero exposure to antidepressant drugs and risk of attention deficit hyperactivity disorder: a nationwide Danish cohort study BMJ Open 3 2013 e003507
13. L.A. Croen, J.K. Grether, C.K. Yoshida, R. Odouli, and V. Hendrick Antidepressant use during pregnancy and childhood autism spectrum disorders Arch Gen Psychiatry 68 2011 1104 1112
14. D. Rai, B.K. Lee, C. Dalman, J. Golding, G. Lewis, and C. Magnusson Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study BMJ 346 2013 2059
15. R.M. Pearson, J. Evans, D. Kounali, and et al. Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years JAMA Psychiatry 70 2013 1312 1319
16. L.S. Cohen, L.L. Altshuler, B.L. Harlow, and et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment JAMA 295 2006 499 507
17. K.A. Yonkers, N. Gotman, M.V. Smith, and et al. Does antidepressant use attenuate the risk of a major depressive episode in pregnancy? Epidemiology 22 2011 848 854
18. M. Gissler, and J. Schelley Quality of data on subsequent events in a routine Medical Birth Register Med Inform Internet Med 27 2002 33 38
19. Population Register Centre. Available at: http://www.vrk.fi/. Accessed September 30, 2015.
20. R. Sund Quality of the Finnish Hospital Discharge Register: a systematic review Scand J Public Health 40 2012 505 515
21. M. Elsabbagh, G. Divan, Y.J. Koh, and et al. Global prevalence of autism and other pervasive developmental disorders Autism Res 5 2012 160 179
22. K.M. Lampi, A. Sourander, M. Gissler, and et al. Brief report: validity of Finnish registry-based diagnoses of autism with the ADI-R Acta Paediatr 99 2010 1425 1428
23. O. Stephansson, F. Granath, T. Svensson, B. Haglund, A. Ekbom, and H. Kieler Drug use during pregnancy in Sweden - assessed by the Prescribed Drug Register and the Medical Birth Register Clin Epidemiol 3 2011 43 50
24. J. Martikainen, R. Pajunen, L. Saastamoinen, and T. Voipio Finnish Statistics on Medicines 2009 2010 Finnish Medicines Agency and the Social Insurance Institution in Finland (Tampere): Juvenes Print and Tampereen Yliopistopaino Oy
25. I. Nulman, G. Koren, J. Rovet, M. Barrera, A. Pulver, and D. Streiner Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression Am J Psychiatry 169 2012 1165 1174
26. T.F. Oberlander, M. Papsdorf, U.M. Brain, S. Misri, C. Ross, and R.E. Grunau Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age Arch Pediatr Adolesc Med 164 2010 444 451
27. S. Misri, B. Reebye, K. Kendrick, D. Carter, D. Ryan, and R.E. Grunau Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications Am J Psychiatry 163 2006 1026 1032
28. T. Boukhris, O. Sheehy, L. Mottron, and A. Bérard Antidepressant use during pregnancy and the risk of autism spectrum disorder in children JAMA Pediatr 170 2016 117 124
29. M. Huhn, M. Tardy, L.M. Spineli, and et al. Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analysis JAMA Psychiatry 71 2014 706 715